Login / Signup

Characterization of Correction Factors to Enable Assessment of Clinical Risk from In Vitro CYP3A4 Induction Data and Basic Drug-Drug Interaction Models.

Diane RamsdenCody L Fullenwider
Published in: European journal of drug metabolism and pharmacokinetics (2022)
These iterative improvements, which reduce the number of false positives, could aid regulatory recommendations and limit unnecessary clinical explorations into CYP3A induction.
Keyphrases
  • emergency department
  • electronic health record
  • magnetic resonance imaging
  • clinical practice
  • machine learning
  • adverse drug
  • computed tomography
  • magnetic resonance
  • artificial intelligence